glp 1 glucose dependent insulin secretion GLP-1 receptor signalling promotes β-cell metabolism via mTOR- HIF-1α activation Glucagon Like Peptide 1 Receptor

GLP-1 may induce sodium excretion by blocking sodium reabsorption in the proximal tubule through inhibition of sodium-hydrogen exchanger isoform 3 (NHE3) activity [23], as no GLP-1 receptors appear to be present in human kidneys outside of the renal vasculature [19]

The medication can treat adults with metabolic dysfunction-associated steatohepatitis (MASH) who have moderate to advanced liver scarring (fibrosis), but not cirrhosis, along with a reduced-calorie diet and increased physical activity

Their effectiveness has been recognized with FDA approval thanks to their capacity for enhancing weight control alongside improving blood sugar regulation

"Long-acting GLP-1 formulations: clinical development and therapeutic potential." Drugs